If cannabis caused schizophrenia - How many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations

Addiction

Volumn 104, Issue 11, 2009, Pages 1856-1861

  Hickman, Matt ^a   Vickerman, Peter ^a,b   MacLeod, John ^a   Lewis, Glyn ^c   Zammit, Stan ^c,d   Kirkbride, James ^e   Jones, Peter ^e  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cannabis; Models; Number needed to prevent; Prevention; Psychosis; Schizophrenia

Indexed keywords

CANNABIS;

ADULT; ARTICLE; CONFIDENCE INTERVAL; DRUG ABUSE; DRUG USE; FEMALE; GROUPS BY AGE; HUMAN; HYPOTHESIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY PREVENTION; PSYCHOSIS; PUBLIC HEALTH; RISK ASSESSMENT; RISK REDUCTION; SCHIZOPHRENIA; UNITED KINGDOM;

ADOLESCENT; ADULT; EPIDEMIOLOGIC METHODS; FEMALE; GREAT BRITAIN; HUMANS; MALE; MARIJUANA ABUSE; PSYCHOSES, SUBSTANCE-INDUCED; RESEARCH DESIGN; SCHIZOPHRENIA; SEX FACTORS; YOUNG ADULT;

EID: 70349849773     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2009.02736.x     Document Type: Article

References (24)

1. Hall W., Pacula R. Cannabis Use and Dependence: Public Health and Public Policy. Cambridge, UK : Cambridge University Press 2003.
2. Advisory Council on the Misuse of Drugs. Cannabis: Classification and Public Health. London : Home Office. 2008. Available from: http://drugs. homeoffice.gov.uk/publication-search/acmd/acmd-cannabis-report-2008 (accessed 17 September 2009).
3. Zammit S., Allebeck P., Andreasson S., Lundberg I., Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002 325 : 1199.
4. Fergusson D. M., Horwood L. J., Swain-Campbell N. R. Cannabis dependence and psychotic symptoms in young people. Psychol Med 2003 33 : 15 21.
5. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T. E. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002 325 : 1212 1213.
6. Macleod J., Oakes R., Copello A., Crome I., Egger M., Hickman M. et al. The psychosocial consequences of use of cannabis and other illicit drugs: systematic review of longitudinal, general population studies. Lancet 2004 363 : 1579 1588. (Pubitemid 38625660)
7. Moore T. H., Zammit S., Lingford-Hughes A., Barnes T. R., Jones P. B., Burke M. et al. Systematic review of cannabis use and risk of developing psychotic or affective mental health outcomes. Lancet 2007 370 : 319 328.
8. Aust R., Sharp C., Goulden C. Prevalence of Drug Use: Key Findings From the 2001/2002 British Crime Survey. Findings 182. London : Home Office 2002.
9. Hickman M., Vickerman P., Macleod J., Kirkbride J., Jones P. B. Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction 2007 102 : 597 606.
10. Degenhardt L., Hall W., Lynskey M. Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend 2003 71 : 37 48. (Pubitemid 36734857)
11. Doll R., Peto R., Boreham J., Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004 328 : 1519.
12. Office of National Statistics. ONS psychiatric morbidity among adults living in private households. 2000. Available at: http://www.statistics.gov.uk/ downloads/theme-health/psychmorb.pdf (accessed August 2009).
13. Kirkbride J. B., Fearon P., Morgan C., Dazzan P., Morgan K., Tarrant J. et al. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-Center AeSOP Study. Arch Gen Psychiatry 2006 63 : 250 258.
14. Rutter M. Identifying The Environmental Causes of Disease. London : Academy of Medical Sciences 2007.
15. Morgan C. J. A., Curran H. V. Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. Br J Psychiatry 2008 192 : 306 307.
16. Nordstrom B. R., Levin F. R. Treatment of cannabis use disorders: a review of the literature. Am J Addict 2007 16 : 331 342.
17. Campbell R., Starkey F., Holliday J., Audrey S., Bloor M., Parry-Langdon N. et al. An informal school-based peer-led intervention for smoking prevention in adolescence (ASSIST): a cluster randomised trial. Lancet 371 : 1595 1602.
18. Faggiano F., Vigna-Taglianti F. D., Versino E., Zambon A., Borraccino A., Lemma P. School-based prevention for illicit drugs' use. Cochrane Database Syst Rev 2005 2 : CD003020.
19. Manuel D. G., Kwong K., Tanuseputro P., Lim J., Mustard C. A., Anderson G. M. et al. Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study. BMJ 2006 332 : 1419.
20. Humphrey L. L., Helfand M., Chan B. K., Woolf S. H. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002 137 : 347 360. (Pubitemid 34977137)
21. Riper H., Kramer J., Smit F., Conijn B., Schippers G., Cuijpers P. Web-based self-help for problem drinkers: a pragmatic randomized trial. Addiction 2008 103 : 218 227.
22. Fergusson D. M., Horwood L. J., Beautrais A. L. Cannabis and educational achievement. Addiction 2003 98 : 1681 1692.
23. Patton G. C., Coffey C., Carlin J. B., Sawyer S. M., Lynskey M. Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction 2005 100 : 1518 1525.
24. Hall W. D. The contribution of research to the development of a national cannabis policy in Australia. Addiction 2008 103 : 712 720.